Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 May;34(2):97-104.
doi: 10.1016/j.evalprogplan.2010.07.003. Epub 2010 Aug 6.

Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States

Affiliations
Randomized Controlled Trial

Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States

David R Lairson et al. Eval Program Plann. 2011 May.

Abstract

Objective: We conducted an economic evaluation of mammography promotion interventions in a population-based, nationally representative sample of 5500 women veterans.

Methods: Women 52 years and older were randomly selected from the National Registry of Women Veterans and randomly assigned to a survey-only control group and two intervention groups that varied in the extent of personalization (tailored vs. targeted). Effectiveness measures were the prevalence of at least one self-reported post-intervention mammogram and two post-intervention mammograms 6-15 months apart. Incremental cost-effectiveness ratios (ICERs) were the incremental cost per additional person screened. Uncertainty was examined with sensitivity analysis and bootstrap simulation.

Results: The targeted intervention cost $25 per person compared to $52 per person for the tailored intervention. About 27% of the cost was incurred in identifying and recruiting the eligible population. The percent of women reporting at least one mammogram were .447 in the control group, .469 in the targeted group, and .460 in the tailored group. The ICER was $1116 comparing the targeted group to the control group (95% confidence interval (CI)=$493 to dominated). The tailored intervention was dominated (more costly and less effective) by the targeted intervention.

Conclusion: Decision-makers should consider effectiveness evidence and the full recruitment and patient time costs associated with the implementation of screening interventions when making investments in mammography screening promotion programs. Identification and recruitment of eligible participants add substantial costs to outreach screening promotion interventions. Tailoring adds substantial cost to the targeted mammography promotion strategy without a commensurate increase in effectiveness. Although cost-effectiveness has been reported to be higher for some in-reach screening promotion interventions, a recent meta-analysis revealed significant heterogeneity in the effect sizes of published health-plan based intervention studies for repeat mammography (i.e., some studies reported null effects compared with control groups).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bootstrap Replicates

Similar articles

Cited by

References

    1. American Cancer Society. Breast Cancer Facts & Figures 2007-2008. Atlanta, GA: American Cancer Society, Inc.; 2007. Ref Type: Report.
    1. Andersen MR, Hager M, Su C, Urban N. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Education & Behavior. 2002;29:755–770. - PubMed
    1. Berg AO, Allan JD, Frame PS, Homer CJ, Johnson MS, Klein JD, Lieu TA, Mulrow CD, Orleans CT, Peipert JF, Pender NJ, Siu AL, Teutsch SM, Westhoff C, Woolf SH. Screening for breast cancer: Recommendations and rationale. Annals of Internal Medicine. 2002;137:344–346. - PubMed
    1. Berry DA. The screening mammography paradox: better when found, perhaps better not to find. British Journal of Cancer. 2008;98:1729–1730. - PMC - PubMed
    1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine. 2005;353:1784–1792. - PubMed

Publication types